FDA Approved Drugs Database
-
Drug Name:
LOPERAMIDE HYDROCHLORIDE
-
Application Number:
217840
-
Product Number:
1
-
Dosage Form:
CAPSULE;ORAL
-
Strength:
2MG
-
Product Type:
RX
-
Active Ingredient:
LOPERAMIDE HYDROCHLORIDE
-
Approval Date:
2023-07-05
-
Legal Name:
-
-
Drug Name:
PHENDIMETRAZINE TARTRATE
-
Application Number:
91042
-
Product Number:
1
-
Dosage Form:
TABLET;ORAL
-
Strength:
35MG
-
Product Type:
RX
-
Active Ingredient:
PHENDIMETRAZINE TARTRATE
-
Approval Date:
2010-08-31
-
Legal Name:
-
-
Drug Name:
SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER
-
Application Number:
207956
-
Product Number:
1
-
Dosage Form:
INJECTABLE;INJECTION
-
Strength:
900MG/100ML
-
Product Type:
RX
-
Active Ingredient:
SODIUM CHLORIDE
-
Approval Date:
2017-05-25
-
Legal Name:
-
-
Drug Name:
TECHNETIUM TC 99M MERTIATIDE KIT
-
Application Number:
216820
-
Product Number:
1
-
Dosage Form:
POWDER;INTRAVENOUS
-
Strength:
N/A
-
Product Type:
RX
-
Active Ingredient:
TECHNETIUM TC-99M MERTIATIDE KIT
-
Approval Date:
2023-01-30
-
Legal Name:
-
-
Drug Name:
OSELTAMIVIR PHOSPHATE
-
Application Number:
213695
-
Product Number:
1
-
Dosage Form:
FOR SUSPENSION;ORAL
-
Strength:
EQ 6MG BASE/ML
-
Product Type:
RX
-
Active Ingredient:
OSELTAMIVIR PHOSPHATE
-
Approval Date:
2025-03-03
-
Legal Name:
-
-
Drug Name:
FLUPHENAZINE HYDROCHLORIDE
-
Application Number:
89742
-
Product Number:
1
-
Dosage Form:
TABLET;ORAL
-
Strength:
5MG
-
Product Type:
-
Active Ingredient:
FLUPHENAZINE HYDROCHLORIDE
-
Approval Date:
-
Legal Name:
-
-
Drug Name:
CETRORELIX ACETATE
-
Application Number:
214540
-
Product Number:
1
-
Dosage Form:
POWDER;SUBCUTANEOUS
-
Strength:
EQ 0.25MG BASE/VIAL
-
Product Type:
RX
-
Active Ingredient:
CETRORELIX ACETATE
-
Approval Date:
2024-04-24
-
Legal Name:
-
-
Drug Name:
MIDOSTAURIN
-
Application Number:
215834
-
Product Number:
1
-
Dosage Form:
CAPSULE;ORAL
-
Strength:
25MG
-
Product Type:
-
Active Ingredient:
MIDOSTAURIN
-
Approval Date:
-
Legal Name:
-
-
Drug Name:
NASONEX 24HR ALLERGY
-
Application Number:
215712
-
Product Number:
1
-
Dosage Form:
SPRAY, METERED;NASAL
-
Strength:
0.05MG/SPRAY
-
Product Type:
OTC
-
Active Ingredient:
MOMETASONE FUROATE
-
Approval Date:
2022-03-17
-
Legal Name:
-
Create a New Buying Request
Fields marked with * are mandatory.